维普中文期刊产品整合服务
146篇 您的检索式:作者名="FONAROW G"
    题名 作者 年代 出处 被引量
1Improvement in exercise capacity of candidates awaiting heart transplantation 显示文摘Stevenson LW Steimle AE Fonarow G 1995J Am Coil Cardiol1995,25,:1
2The dissociation between door-to-balloon time improvement and improvements in other acute myo- cardial infarction care processes and patient outcomes 显示文摘WANG T Y FONAROW G C HERNANDEZ A F 2009Arch InternMed2009,169,:1
3Beta blocker and angiotensin-converting enzyme inhibitor therapy is associated with decreased Th1/Th2 cytokine ratios and inflammatory cytokine production in patients with chronic heart failure 显示文摘Gage J R Fonarow G Hamilton M 2004Neuroimmunomodulation2004,11,3:1
4Improvement in exer- cise capacity of candidates awaiting heart transplantation显示文摘Stevenson LW Steimle AE Fonarow G 1995J Am Coll Cardiol1995,25,1:1
5Randomized clinical outcome trials of statins in heart failure 显示文摘FONAROW G C 2008Heart Fail Clin2008,4,2:1
6Epidemiology and risk profile of heart failure显示文摘Bui AL Horwich TB Fonarow G C 2011Nat Rev Cardio2011,8,1:1
7Cholesterol and mortality in heart failure:the bad gone good显示文摘Fonarow G C Horwich T B 0,,11:1
8Treating to goal: new strategies for initiating and optimizing lipid-lowering therapy in patients with atherosclerosis 显示文摘Fonarow G C 2002Vasc Med2002,7,3:1
9Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP)显示文摘Fonarow G C Gawlinski A Moughrabi S 2001Am J Cardiol2001,87,7:1
10Interleukin - 6 (IL- 6)expression and natural killer (NK) cell dysfunction and anergy in heart failure显示文摘VREDEVOE D L WIDAWSKI M FONAROW G C 2004Am J Cardiol2004,93,8:1
11Depression in patients with heart failure 显示文摘Westlake C Dracup K Fonarow G 2005J Card Fail2005,11,1:1
12Beta blocker and angiotensin- converting enzyme inhibitor therapy is associated with decreased Thl/ Th2 cytokine ratios and inflammatory cytokine production in patients with chronic heart failure显示文摘Gage JR Fonarow G Hamilton M 2004Neuroimmunomodulation2004,11,3:1
13Epidemiology and risk profile of heart failure显示文摘Bui A L Horwich T B Fonarow G C 0,,1:1
14Interleukin-6(IL-6) expression and natural killer(NK) cell dysfunction and anergy in heart failure显示文摘VREDEVOE D L WIDAWSKI M FONAROW G 2004Am J Cardiol2004,93,:1
15Statin therapy is associated with improved survival in ischemic and non ischemic heart failure显示文摘HORWICH T B MACLELLAN W R FONAROW G C 2004J Am Coll Cardiol2004,43,4:1
16冠心病和其他动脉粥样硬化性血管疾病二级预防指南:2006年版(摘要)显示文摘美国心脏学会(American College of Cardiology,ACC)与美国心脏病协会(American Heart Association.AHA)关于二级预防的共识声明自2001年更新以来,许多临床试验提供了重要证据.进一步支持和拓展了对冠心病和其他动脉粥样硬化性血管疾病(包括外周动脉疾病、动脉粥样硬化性主动脉疾病和颈动脉疾病)进行积极控制危险因素治疗的重要性。证据不断涌现,证实对这些患者进行积极而全面的危险因素干预治疗能够改善生存率,减少事件复发以及对介入治疗的需要.并提高生活质量。SMITH S C ALLEN J BLAIR S N BONOW R O BRASS L M FONAROW G C GRUNDY S M HIRATZKA L JONES D KRUMHOLZ H M MOSCA L PASTERNAK R C PEARSON T PFEFFER M A TAUBERT K A 2008岭南心血管病杂志2008,14,2:1
17Characteristics,treatments,and outcomes of patients with preserved systolic function hospitalized for heart failure:a report from the OPTIMIZE-HF Registry显示文摘FONAROW G C STOUGH W G ABRAHAM W T 2007J Am Coil Cardiol2007,50,8:1
18Beta blocker and angiotensin-converting enzyme inhibitor therapy is associated with decreased Thl/Th2 cytokine ratios and inflammatory cy- tokine production in patients with chronic heart failure 显示文摘Gage JR Fonarow G Hamilton M 20042004, 11(3): 173-1802004,11,3:1
19Depression in patients with heart failure显示文摘Westlake C Dracup K Fonarow G 2005J Cardiac Fail2005,11,1:1
20Total cholesterol levels and mortality risk in nonischemic systolic heart failure 显示文摘Afsarmanesh N Horrwich T B Fonarow G C 2006Am Heart J2006,152,6:1
返回顶部 每页显示:
共8页 首页 上一页 第1页 下一页 末页 /8 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费